Free Trial

AQR Arbitrage LLC Invests $19.74 Million in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

AQR Arbitrage LLC Invests $19.74 Million in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

AQR Arbitrage LLC bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 1,980,285 shares of the company's stock, valued at approximately $19,743,000. AQR Arbitrage LLC owned about 8.83% of Oaktree Acquisition Corp. III Life Sciences at the end of the most recent quarter.

Separately, Shaolin Capital Management LLC acquired a new position in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter worth $5,478,000.

Oaktree Acquisition Corp. III Life Sciences Price Performance

NASDAQ:OACC remained flat at $10.43 during mid-day trading on Tuesday. The company had a trading volume of 12,199 shares, compared to its average volume of 103,095. The company has a fifty day simple moving average of $10.17. Oaktree Acquisition Corp. III Life Sciences has a fifty-two week low of $9.95 and a fifty-two week high of $10.85.

About Oaktree Acquisition Corp. III Life Sciences

(Free Report)

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.

Featured Articles

Institutional Ownership by Quarter for Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

Should You Invest $1,000 in Oaktree Acquisition Corp. III Life Sciences Right Now?

Before you consider Oaktree Acquisition Corp. III Life Sciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oaktree Acquisition Corp. III Life Sciences wasn't on the list.

While Oaktree Acquisition Corp. III Life Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines